Transapical transcatheter aortic valve implantation using a new second-generation TAVI system -J-Valve (TM) for high-risk patients with aortic valve diseases: Initial results with 90-day follow-up

摘要

Background: To evaluate the safety and efficacy of transcatheter aortic valve implantation (TAVI) for patients with aortic stenosis (AS) or pure/dominant aortic regurgitation (AR) using the J-Valve (TM) system.